| Literature DB >> 35301378 |
Mi Zhou1, Zhi Zhu2, Hui-Zeng Sun3, Ke Zhao4, Mike E R Dugan5, Heather Bruce1, Carolyn Fitzsimmons1,5, Changxi Li1,5, Le Luo Guan6.
Abstract
The current study aimed to determine whether breed and feed efficiency affect the molecular mechanisms regulating beneficial and non-beneficial fatty acid profiles in subcutaneous adipose tissue of beef steers. Fatty acid profiling and RNA-Seq based transcriptome analysis were performed on subcutaneous adipose tissues collected from beef steers with three divergent breeds (Angus, ANG, n = 47; Charolais, CHAR, n = 48; Kinsella Composite, KC, n = 48) and different residual feed intake (RFI, a measure of feed efficiency). The comparison of fatty acid profiles showed that KC had higher beneficial FAs compared to the other two breeds. Distinct FA profiles between H-RFIfat and L-RFIfat steers was more obvious for KC steers, where H-RFIfat steers tended to have higher proportion of healthy FAs and lower proportion of the unhealthy FAs. A higher number of differentially expressed (DE) genes were observed for KC steers, whereas ANG and CHAR steers had a lower number of DE genes between H- and L-RFIfat steers. The association analyses of the gene expressions and FA profiles showed that 10 FA metabolism-associated genes together with the one upstream regulator (SREBF1) were associated with the proportion of C18:2n-6, total n-6, PUFA and PUFA/SFA for KC steers but not the other two breeds. Subcutaneous adipose tissue FA profiles and healthy FA index differed in cattle with divergent feed efficiency and such variation was unique for the three examined cattle breeds. Key FA metabolism-associated genes together with SREBF1 which is the upstream regulator of a set of genes involved in lipid metabolism may be of importance for genetic selection of meat with higher healthy FA index in beef cattle.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35301378 PMCID: PMC8931072 DOI: 10.1038/s41598-022-08572-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Effects of different breeds on performance traits of beef cattle.
| Trait* | ANG1 | CHAR2 | KC3 | SEM | |
|---|---|---|---|---|---|
| DMI (kg) | 11.46a | 10.66b | 10.16b | 0.120 | < .0001 |
| ADG (kg) | 1.72a | 1.62ab | 1.52b | 0.024 | 0.003 |
| RFIfat (kg) | 0.18 | 0.02 | − 0.05 | 0.075 | 0.459 |
| Backfat thickness (mm) | 11.35a | 8.55b | 11.44a | 0.280 | < .0001 |
| Marbling score | 423.04a | 404.58a | 373.37b | 4.945 | 0.000 |
*DMI = dry matter intake; ADG = average daily gain; RFIfat = residual feed intake adjusted for backfat thickness.
1Angus breed; 2Charolais breed; 3Kinsella Composite breed.
Means in the same row with different superscripts (a, b) indicate significance (p < 0.05).
Effects of different breeds on fatty acid proportion (%) in subcutaneous tissues of beef cattle.
| Trait* | ANG | CHAR | KC | SEM | |
|---|---|---|---|---|---|
| 14:0 | 3.78b | 4.16a | 3.90ab | 0.056 | 0.017 |
| 16:0 | 28.39a | 26.56b | 27.11b | 0.172 | < 0.0001 |
| 18:0 | 11.80 | 11.70 | 11.11 | 0.024 | 0.307 |
| SFA | 46.03a | 44.36b | 43.91b | 0.277 | 0.004 |
| BCFA | 1.35b | 1.65a | 1.39b | 0.024 | < 0.0001 |
| SFA + BCFA | 47.38a | 46.01b | 45.30b | 0.286 | 0.010 |
| 4.84b | 5.61a | 5.40a | 0.095 | 0.002 | |
| 37.71ab | 36.88b | 38.46a | 0.224 | 0.014 | |
| 1.72b | 2.01a | 1.90ab | 0.040 | 0.010 | |
| 1.17b | 1.47a | 1.01b | 0.053 | 0.001 | |
| 2.53b | 3.22a | 2.54b | 0.067 | < 0.0001 | |
| MUFA | 50.72b | 51.66ab | 52.47a | 0.281 | 0.038 |
| ADFA | 0.44b | 0.54a | 0.53a | 0.009 | < 0.0001 |
| CLA | 0.28b | 0.28b | 0.43a | 0.011 | < 0.0001 |
| n-6 | 1.03c | 1.35a | 1.11b | 0.019 | < 0.0001 |
| 18:3n-3 | 0.11b | 0.13a | 0.12b | 0.003 | 0.002 |
| PUFA | 1.14c | 1.48a | 1.24b | 0.021 | < 0.0001 |
| PUFA/SFA | 0.025c | 0.034a | 0.028b | 0.001 | < 0.0001 |
| FA ratio | 0.025c | 0.029b | 0.033a | 0.001 | < 0.0001 |
| SCD proxy | 0.27b | 0.26b | 0.30a | 0.004 | 0.008 |
*The concentrations of fatty acids were expressed as a percentage of fatty acid methyl esters (FAME) quantified. Significant effects (p < 0.05) of breed on fatty acid are presented. c = cis; t = trans; SFA (sum of saturated fatty acid) = 10:0 + 12:0 + 14:0 + 15:0 + 16:0 + 17:0 + 18:0 + 19:0 + 20:0; BCFA (sum of branched chain fatty acid) = iso−14:0 + iso-15:0 + anteiso-15:0 + iso-16:0 + iso-17:0 + anteiso-17:0 + iso-18:0; SFA + BCFA = sum of SFA and BCFA; trans-18:1 (sum of trans-18:1) = t6-18:1 + t9-18:1 + t10-18:1 + t11-18:1 + t12-18:1 + t13-/t14-18:1; MUFA (sum of monounsaturated fatty acid) = c9-14:1 + c7-16:1 + c9-16:1 + c11-16:1 + c9-17:1 + c9-18:1 + c11-18:1 + c12-18:1 + c13-18:1 + c14-18:1 + t6-18:1 + t9-18:1 + t10-18:1 + t11-18:1 + t12-18:1 + t13-/t14-18:1 + c9-20:1 + c11-20:1; ADFA (sum of atypical dienes fatty acid) = c9,t14-/c9,t13-18:2 + c9,t15-18:2 + c9,t12-18:2 + t11,c15-18:2 + c9,c15-18:2; CLA (sum of conjugated linoleic acid) = t7,c9-18:2 + c9,t11-18:2 + t9,c11-18:2 + t11,t13-18:2 + t7,t9-/t10,t12-18:2; n-6 (sum of omega 6 fatty acids) = 18:2n-6 + 20:3n-6 + 20:4n-6; n-3 (sum of omega 3 fatty acids) = 18:3n-3; PUFA (sum of polyunsaturated fatty acid) = 18:2n-6 + 20:3n-6 + 20:4n-6 + 18:3n-3; PUFA/SFA = ratio of PUFA to SFA; n-6/n-3 = ratio of n − 6 to n − 3 PUFA; FA ratio = (18:3n-3 + c9,t11-18:2 + t11-18:1)/(14:0 + 16:0 + t10-18:1); SCD proxy (stearoyl-CoA desaturase proxy) = c9-14:1/(c9-14:1 + 14:0).
Means in the same row with different superscripts (a, b, c) indicate significance (p < 0.05).
Only major FAs/FA groups are listed in this table. Detailed proportions of the FAs of individual samples are listed in Supplementary Table S6.
Effects of breed and residual feed intake adjusted for backfat thickness (RFIfat) on fatty acid proportion (%) in subcutaneous tissues and performance traits of beef cattle.
| Trait* | ANG1 | CHAR2 | KC3 | SEM | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| H-RFIfat4 | L-RFIfat5 | H-RFIfat | L-RFIfat | H-RFIfat | L-RFIfat | Breed | RFIfat | Breed × RFIfat | |||||
| 14:0 | 3.75bc | 3.89abc | 0.463 | 4.32a | 4.13ab | 0.426 | 3.66c | 4.05abc | 0.126 | 0.069 | 0.029 | 0.405 | 0.197 |
| 16:0 | 28.07a | 28.29a | 0.769 | 27.01ab | 26.16b | 0.156 | 26.21b | 27.67a | 0.029 | 0.200 | 0.003 | 0.466 | 0.038 |
| 18:0 | 12.13 | 11.56 | 0.566 | 11.98 | 11.85 | 0.863 | 11.02 | 10.81 | 0.791 | 0.240 | 0.159 | 0.534 | 0.933 |
| SFA | 45.90a | 45.79a | 0.903 | 45.29a | 43.99ab | 0.204 | 42.64b | 44.30ab | 0.209 | 0.333 | 0.014 | 0.895 | 0.156 |
| BCFA | 1.32c | 1.44bc | 0.232 | 1.67a | 1.61ab | 0.549 | 1.43c | 1.38c | 0.496 | 0.028 | < .0001 | 0.928 | 0.299 |
| SFA + BCFA | 47.22a | 47.23a | 0.986 | 46.96a | 45.60ab | 0.207 | 44.06b | 45.68ab | 0.237 | 0.347 | 0.019 | 0.894 | 0.183 |
| 4.84c | 4.93bc | 0.843 | 5.51abc | 5.77a | 0.523 | 5.39abc | 5.66ab | 0.457 | 0.116 | 0.025 | 0.370 | 0.936 | |
| 38.01ab | 37.69ab | 0.720 | 36.25b | 37.48b | 0.162 | 39.29a | 37.97ab | 0.186 | 0.274 | 0.024 | 0.804 | 0.134 | |
| 1.69 | 1.67 | 0.908 | 1.88 | 1.99 | 0.485 | 1.98 | 1.87 | 0.549 | 0.049 | 0.072 | 0.953 | 0.615 | |
| 1.11ab | 1.09ab | 0.913 | 1.29a | 1.33a | 0.804 | 1.06ab | 0.95b | 0.456 | 0.050 | 0.039 | 0.767 | 0.790 | |
| 2.48c | 2.51c | 0.889 | 3.08a | 3.05ab | 0.880 | 2.64bc | 2.44c | 0.337 | 0.069 | 0.001 | 0.604 | 0.744 | |
| MUFA | 50.91b | 50.86b | 0.963 | 50.72b | 52.21ab | 0.169 | 53.56a | 52.17ab | 0.301 | 0.343 | 0.049 | 0.982 | 0.207 |
| ADFA | 0.44b | 0.45b | 0.822 | 0.54a | 0.53a | 0.798 | 0.55a | 0.53a | 0.364 | 0.010 | < .0001 | 0.607 | 0.757 |
| CLA | 0.27b | 0.28b | 0.902 | 0.23b | 0.27b | 0.413 | 0.47a | 0.43a | 0.210 | 0.014 | < .0001 | 0.925 | 0.418 |
| n-6 | 1.01c | 1.02c | 0.798 | 1.36a | 1.23b | 0.097 | 1.19b | 1.03c | 0.002 | 0.022 | < .0001 | 0.012 | 0.122 |
| 18:3n-3 | 0.12b | 0.12b | 0.969 | 0.14a | 0.12ab | 0.107 | 0.13ab | 0.12b | 0.446 | 0.003 | 0.145 | 0.195 | 0.543 |
| PUFA | 1.13c | 1.14c | 0.828 | 1.51a | 1.36b | 0.082 | 1.32b | 1.15c | 0.003 | 0.023 | < .0001 | 0.013 | 0.140 |
| PUFA/SFA | 0.024b | 0.025b | 0.778 | 0.033a | 0.031a | 0.198 | 0.031a | 0.026b | 0.003 | 0.001 | < .0001 | 0.015 | 0.074 |
| n-6/n-3 | 9.06b | 9.13ab | 0.928 | 9.88ab | 10.42a | 0.435 | 9.77ab | 8.83b | 0.042 | 0.184 | 0.049 | 0.765 | 0.212 |
| FA ratio | 0.025c | 0.027bc | 0.512 | 0.030bc | 0.029bc | 0.687 | 0.036a | 0.031ab | 0.093 | 0.001 | 0.0004 | 0.479 | 0.288 |
| SCD proxy | 0.27ab | 0.28ab | 0.647 | 0.27b | 0.26b | 0.912 | 0.30a | 0.30a | 0.999 | 0.005 | 0.013 | 0.841 | 0.924 |
| DMI (kg) | 12.49a | 10.73c | 0.001 | 11.87ab | 9.83d | < .0001 | 11.29bc | 9.24d | < .0001 | 0.156 | < .0001 | < .0001 | 0.826 |
| ADG (kg) | 1.62ab | 1.79a | 0.132 | 1.65ab | 1.62ab | 0.661 | 1.54b | 1.51b | 0.762 | 0.027 | 0.021 | 0.465 | 0.206 |
| Backfat thickness (mm) | 11.13a | 11.28a | 0.899 | 8.06b | 8.25b | 0.830 | 10.74a | 11.93a | 0.271 | 0.332 | < .0001 | 0.397 | 0.720 |
| Marbling score | 433.33a | 409.29ab | 0.257 | 400.00abc | 381.18bc | 0.331 | 380.33bc | 367.37c | 0.370 | 5.520 | 0.002 | 0.078 | 0.912 |
*c = cis; t = trans; SFA (sum of saturated fatty acid) = 10:0 + 12:0 + 14:0 + 15:0 + 16:0 + 17:0 + 18:0 + 19:0 + 20:0; BCFA (sum of branched chain fatty acid) = iso-14:0 + iso-15:0 + anteiso-15:0 + iso-16:0 + iso-17:0 + anteiso-17:0 + iso-18:0; SFA + BCFA = sum of SFA and BCFA; trans-18:1 (sum of trans-18:1) = t6-18:1 + t9-18:1 + t10-18:1 + t11-18:1 + t12-18:1 + t13-/t14-18:1; MUFA (sum of monounsaturated fatty acid) = c9-14:1 + c7-16:1 + c9-16:1 + c11-16:1 + c9-17:1 + c9-18:1 + c11-18:1 + c12-18:1 + c13-18:1 + c14-18:1 + t6-18:1 + t9-18:1 + t10-18:1 + t11-18:1 + t12-18:1 + t13-/t14-18:1 + c9-20:1 + c11-20:1; ADFA (sum of atypical dienes fatty acid) = c9,t14-/c9,t13-18:2 + c9,t15-18:2 + c9,t12-18:2 + t11,c15-18:2 + c9,c15-18:2; CLA (sum of conjugated linoleic acid) = t7,c9-18:2 + c9,t11-18:2 + t9,c11-18:2 + t11,t13-18:2 + t7,t9-/t10,t12-18:2; n-6 (sum of omega 6 fatty acids) = 18:2n-6 + 20:3n-6 + 20:4n-6; n-3 (sum of omega 3 fatty acids) = 18:3n-3; PUFA (sum of polyunsaturated fatty acid) = 18:2n-6 + 20:3n-6 + 20:4n-6 + 18:3n-3; PUFA/SFA = ratio of PUFA to SFA; n-6/n-3 = ratio of n − 6 to n − 3 PUFA; FA ratio = (18:3n-3 + c9,t11-18:2 + t11-18:1)/(14:0 + 16:0 + t10-18:1); SCD proxy (stearoyl-CoA desaturase proxy) = c9-14:1/(c9-14:1 + 14:0); DMI = dry matter intake; ADG = average daily gain.
#Statistical analysis was performed within each breed.
1Angus breed; 2Charolais breed; 3Kinsella Composite breed; 4High RFIfat steers (RFIfat > 0.5); 5Low RFIfat steers (RFIfat < − 0.5).
Means in the same row with different superscripts (a, b, c, d) indicate significance (p < 0.05).
Only major FAs/FA groups are listed in this table.
Figure 1Differential abundant FAs between H-RFI and L-RFI steers as analyzed for each cattle breed respectively. Significance was indicated as follows: **p < 0.01; *0.01 ≤ p < 0.05; #0.05 ≤ p < 0.1.
Figure 2Correlations between FA profiles and RFI for the three breeds. The correlations of statistical significance (p < 0.05) identified from the KC breed were highlighted in red square.
Figure 3Functional classification of differentially expressed genes using IPA (Ingenuity Pathway Analysis) in different breeds of beef cattle. Positive z-scores are indicated with red bars and negative z-scores with blue bars. A positive z-score (2) indicates an increased predicted activation state, while a negative z-score (− 2) indicates a reduction in function. The number to the right of the bar is the number of differentially expressed (DE) genes. Up arrow and down arrow represent the DE genes up- and down-regulated in L-RFIfat compared to H-RFIfat steers, respectively. ANG, Angus; CHAR, Charolais; KC, Kinsella Composite.
GO term enrichment results of all differentially expressed genes using IPA within each breed.
| Breed | Category | Module | Functions | z-score† | Predicted action | Involved genes | |
|---|---|---|---|---|---|---|---|
| ANG | Organismal survival | 17 | Organismal death | 3.527 | 0.000 | Activated | |
| 18 | Morbidity or mortality | 3.285 | 0.000 | Activated | |||
| 6 | Perinatal death | 2.421 | 0.005 | Activated | |||
| Organismal injury and abnormalities | 5 | Edema | 2.000 | 0.003 | Activated | ||
| Cell signaling, molecular transport, vitamin and mineral metabolism | 5 | Quantity of Ca2+ | −2.143 | 0.004 | Inhibited | ||
| Cellular development, cellular growth and proliferation | 6 | Cell proliferation of breast cancer cell lines | −2.168 | 0.002 | Inhibited | ||
| Carbohydrate metabolism | 7 | Metabolism of carbohydrate | −2.173 | 0.001 | Inhibited | ||
| 6 | Synthesis of carbohydrate | −2.191 | 0.001 | Inhibited | |||
| Cellular movement | 12 | Cell movement of tumor cell lines | −2.182 | 0.000 | Inhibited | ||
| 5 | Invasion of breast cancer cell lines | −2.183 | 0.001 | Inhibited | |||
| 8 | Migration of tumor cell lines | −2.235 | 0.001 | Inhibited | |||
| 19 | Migration of cells | −3.475 | 0.000 | Inhibited | |||
| 20 | Cell movement | −3.747 | 0.000 | Inhibited | |||
| Cell-to-cell signaling and interaction | 6 | Aggregation of cells | −2.183 | 0.000 | Inhibited | ||
| Molecular transport | 6 | Quantity of metal | −2.348 | 0.002 | Inhibited | ||
| Cellular movement, hematological system development and function, immune cell trafficking | 11 | Cell movement of leukocytes | −2.571 | 0.000 | Inhibited | ||
| Cellular assembly and organization, cellular function and maintenance | 10 | Microtubule dynamics | −2.706 | 0.002 | Inhibited | ||
| 11 | Organization of cytoskeleton | −2.861 | 0.002 | Inhibited | |||
| Organismal development | 8 | Size of body | −2.781 | 0.002 | Inhibited | ||
| CHAR | Infectious diseases | 5 | Infection of mammalia | 2.190 | 0.000 | Activated | |
| KC | Energy production | 6 | Consumption of oxygen | 2.449 | 0.004 | Activated | |
| Cell death and survival, embryonic development | 5 | Apoptosis of embryonic cells | 2.236 | 0.001 | Activated | ||
| Endocrine system development and function, molecular transport, small molecule biochemistry | 10 | Concentration of hormone | −2.146 | 0.005 | Inhibited | ||
| Connective tissue development and function, tissue morphology | 20 | Quantity of connective tissue | −2.298 | 0.000 | Inhibited | ||
| Lipid metabolism, molecular transport, small molecule biochemistry | 11 | Concentration of triacylglycerol | −2.319 | 0.000 | Inhibited | ||
| Nutritional disease | 17 | Obesity | −2.531 | 0.000 | Inhibited |
†z-score ≥ 2 and z-score ≤ − 2 indicate Activated and Inhibited activation state.
Predicted function of differentially expressed (DE) genes in subcutaneous adipose tissue of involved in the predicted lipid metabolic function using IPA.
| Predicted functions | z-score† | DE gene* | Gene description | log2FC# | Adjusted P value | Location |
|---|---|---|---|---|---|---|
Concentration of triacylglycerol (KC) | −2.319 | delta like non-canonical Notch ligand 1 | 2.474 | 0.002 | Plasma Membrane | |
| leptin receptor | 2.057 | 0.024 | Membrane | |||
| toll like receptor 5 | 1.617 | 0.012 | Plasma Membrane | |||
| pyruvate dehydrogenase kinase 4 | 1.230 | 0.046 | Cytoplasm | |||
| ATP citrate lyase | −1.364 | 0.045 | Cytoplasm | |||
| cell death-inducing DFFA-like effector a | −1.012 | 0.017 | Cytoplasm | |||
| G0/G1 switch 2 | −1.583 | 0.013 | Cytoplasm | |||
| low density lipoprotein receptor | −1.653 | < 0.001 | Plasma Membrane | |||
| major facilitator superfamily domain containing 2A | −1.611 | 0.046 | Plasma Membrane | |||
| serpin family E member 1 | −1.464 | 0.001 | Extracellular Space | |||
| sterol regulatory element binding transcription factor 1 | −1.140 | < 0.001 | Nucleus |
†z-score ≥ 2 and z-score ≤ − 2 indicate Activated and Inhibited activation state.
*Differentially expressed genes were based on pairwise comparison between H- and L-RFIfat with FDR ≤ 0.1 and |log2FC|≥ 1 as cut-off.
#Log2FC ≥ 1 and log2FC ≤ − 1 indicate up- and down-regulation of a gene in L-RFIfat compared to H-RFIfat steers, respectively.
Figure 4Spearman correlation analysis among the DE gene reads, and between the DE gene reads and FA composition. The correlation coefficient is colored by different intensities of red (positive correlation) and blue (negative correlation). DLK1 = delta like non-canonical Notch ligand 1; LEPR = leptin receptor; TLR5 = toll like receptor 5; PDK4 = pyruvate dehydrogenase kinase 4; ACLY = ATP citrate lyase; CIDEA = cell death-inducing DFFA-like effector a; G0S2 = G0/G1 switch 2; LDLR = low density lipoprotein receptor; MFSD2A = major facilitator superfamily domain containing 2A; SERPINE1 = serpin family E member 1; SREBF1 = sterol regulatory element binding transcription factor 1; n-6 (sum of omega 6 fatty acids) = 18:2n-6 + 20:3n-6 + 20:4n-6; PUFA (sum of polyunsaturated fatty acid) = 18:2n-6 + 20:3n-6 + 20:4n-6 + 18:3n-3; PUFA/SFA = ratio of PUFA to SFA.